Zuranolone is a huge triumph for PPD — but it could negatively impact women’s health research.
The first-ever FDA-approved pill for postpartum depression is a landmark achievement, but it could come at a high cost for women in more ways than one.
Learn more.
Contact Anna at: [email protected]
Back to the Alumni News list.